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Abstract. A cohort of 570 untreated pregnant women from Burkina Faso was studied 
to assess the influence of epidemiologic factors on malaria infection, which was quantified 
as the mean of serial, season-adjusted parasitemia measuremects (mean parasite density 
[MPD]) carried out during the last five months of gestation. A significant effect of the area 
of maternal residence on the MPD was found ( P  < 0.003) and was probably. due to 
geographic differences in mosquito transmission conditions. The strong relationship ob- 
served between parity and malaria infection ( P  < O.OOOl), with MPD levels decreasing as 
the number of gestations increased, confirms that primigravidae are a high-risk group whose 
protection should be a priority. After adjustment for two relevant epidemiologic factors 
(i.e., area of residence and parity), the residual MPD values fitted a mixture of two distri- 
butions. This result supports the view that a major gene is involved in the determination 
of malaria infection intensities and is consistent with the results of a recent familial study 
in Cameroon. 
It is known that pregnancy predisposes women 
to malaria infection, which is a cause of maternal 
morbidity and retarded intrauterine growth.l-s 
The mechanisms of this increased susceptibility, 
which may involve an impairment of immunity 
during pregnancy, are not clearly under~tood.~. s. 
Cross-sectional epidemiologic studies have shown 
the influence of panty on malaria infection, with 
primigravidae being more frequently and more 
severely infected than m~ltigravidae.~-' How- 
ever, as far as we know, no longitudinal study 
with a followup of untreated pregnant women 
has been reported. 
In Burkina Faso, chemoprophylaxis was not 
believed to significantly reduce morbidity and 
mortality, and the only recommendation of the 
Ministry of Health was chloroquine treatment 
of febrile episodes. As a result, a randomized 
trial of chloroquine prophylaxis in pregnant 
women was then conducted between 1987 and 
1988 in  the southwestern part of the country.* 
The control group in this trial consisted of a 
cohort of women who were not given any pro- 
phylaxis during pregnancy. The aim of this trial 
was to study the factors that influenced the lev- 
els of peripheral parasitemia observed in the 
women from this contro1 group who were fol- 
lowed until delivery. 
SUBJECTS AND METHODS 
Subjects 
The randomized trial was carried out in the 
city of Banfora, which is located in the south- 
western part of Burkina Faso. The city is divided 
into seven administrative districts, with a total 
population of approximately 35,000. The study 
area is a semi-rural zone of Sudan savanna, where 
malaria transmission is seasonal and strongly in- 
fluenced by rainfall. At the time of the study, 
there was a unique Mother and Child Health 
Centre in Banfora that was associated with the 
the Province Hospital. 
The details of the trial have been described 
elsewhere8 and will be briefly summarized. From 
February 1987 to February 1988, all pregnant 
women attending the Mother and Child Health 
Centre were included in the study and randomly 
divided into two groups. One of these groups (n 
= 745) received a weekly prophylaxis of 300 mg 
of chloroquine, while the control group (n = 7 19) 
did not receive any prophylaxis. All women were 
visited once a week by investigators, asked about 
febrile episodes or intake of drugs since the last 
visit, and bled by fingerprick every two weeks to 
measure parasite densities.. EtRS~DfiI Fonds Eaau 
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Laboratory methods 
Thick blood films were stained with Giemsa. 
Asexual parasites and leukocytes were counted 
in 100 fields, and the parasite density per mil- 
liliter was calculated assuming an average of 8,000 
leuk~cytes/ml.~ Laboratory technicians had no 
information on the status of the individuals from 
whom the blood samples had been taken. Plas- 
modium falcipanrm accounted for 95% of the 
detected parasites and P. malariae for the re- 
maining 5%. Since we were interested in the risk 
factors of global malaria infection, the parasite 
density considered for analysis was the total par- 
asitemia due to both species of Plasmodium. 
Statistical methods 
Each of the women had several measurements 
of the parasite density (range 2-14, mean = 6) 
made during the followup period. Additional 
analyses of parasite density (PD) was conducted 
using a logarithmic transformation based on log 
(PD + 1) to allow for zero counts; the log-trans- 
formed parasites density will be designated as 
the LPD. To deal with a unique variable ac- 
counting for the intensity of malaria infection, a 
mean parasite density (MPD) was determined. 
Before calculating the MPD, we tested by anal- 
ysis of variance the effect of two time-dependent 
factors that could influence the LPD values: the 
gestational period (i.e., the month of gestation 
when the parasitemia was measured) and the sea- 
son when the measurement took place. The LPD 
values were then adjusted for the effect of the 
relevant factors as described in the Results, and 
for each woman, the MPD was then computed 
as the mean of her adjusted LPD values. 
The five measured factors tested in this anal- 
ysis as potentially influencing the MPD were 1) 
area of residence (seven areas), 2) parity, which 
was divided into four subgroups: a) first gestation 
(pregnancy) (n = 88); b) second gestation (n = 
90); c) third gestation (n = 76); and d) more than 
three gestations (n = 316), 3) ethnic origin, clas- 
sified as five major groups (Bobo-Dioula, Mossi, 
Peul, Senoufo, and others, including Dagan, 
Samo, and more than 20 additional minor 
groups), 4) hemoglobin genotype, determined for 
5 1 1 women who agreed to venipuncture: AA (n 
= 387); AS (n = 38); AC (n = 83); and CC (n = 
3), and 5) age in years, considered as a quanti- ni@@ tative variable. Statistical analyses were per- 
14 
formed using analysis of variance for categorical 
data and linear regression analysis for age by 
means ofthe statistical analysis system. The MPD 
values were then adjusted for the significant fac- 
tors, as described in the Results. 
To assess the possible role of genetic factors 
in the levels of parasite densities, a commingling 
analysis was performed on the MPD values ad- 
justed for the relevant epidemiologic factors. Ev- 
idence for a mixture of normal distributions ac- 
counting for the adjusted data is consistent with 
a major Mendelian gene being involved in the 
determination of the MPD levels, but this can 
be confounded by skewness in the sample dis- 
tr ib~tion.~.  Io Therefore, the presence of a mix- 
ture of up to three normal distributions can be 
tested, while correcting for residual skewness by 
means of a classic power transf~rmation.~ The 
power transformation parameter p is estimated 
either on the assumption that the MPD values 
follow a normal distribution in the sample or on 
the assumption that the MPD values follow a 
mixture of normal distributions. Skewness in the 
distribution is tested by comparing a model in 
which p = 1 (Corresponding to no transforma- 
tion) against a model in which p is estimated. 
Maximum likelihood estimates of the relevant 
parameters and tests of various hypotheses using 
the likelihood-ratio criterion" were camed out 
using the computer program SKUMIX (popu- 
lation Genetics Laboratory, University of Ha- 
waii, Honolulu, HI).9* l '  
RESULTS 
Description of the population 
Of the 719 women in the control group, we 
excluded women with twins (n = 8) and women 
whose pregnancy outcomes were unknown (n = 
141), mostly because they had moved from the 
study area andor  because they gave birth at 
home. These 141 women differed significantly 
from the other women by their ethnic origin, 
since more women who originated from the 
northern part of the country (Peul group) left the 
study area before giving birth. However, the 
women excluded were comparable with the other 
women in the study for all other factors (area of 
residence, parity, and age), and the MPD values 
did not differ significantly in both groups. 
A large majority of the 570 remaining women 
were enrolled in the study between the fourth 
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TABLE 1 TABLE 2
on the mean parasite density 
Characteristics of the study population by intake of an- Results of statistical analysis of the effect of risk factors 
timalarial drugs 
Antimalarial malmen1 Variable P 
O O N N P N -  U ----o-- 
0 0 ~ 0 0 0 0  x 
p o o o o o o o  
+I +I t l  $1 +I $1 +I +I 
1 m. o. -. ". -.o 9 ""-U0 o 
I I  
NO Yes Panty ~0.0001 
Characteristics No. (%) No. (%) P* Area of residence <0.003 
.Y."""I 
Ethnic group 0.48 
Hemoglobin genotype 0.69 
* Elfeet of age disappeared after adjustment far parity. 
<20 86 (16.3) 8 (14.0) 
20-24 161 (30.5) 17 (29.8) 
25-29 
30-34 87 (16.5) 9 (15.8) 
138 (26'1) l4 (24'6) Ns 
235 56 (io.6j 9 (15.8) 
Gestation rank 
1 82 (15.3) 7 (12.3) 
2 84 (15.6) 12 (21.0) NS 
3 71 (13.2) 5 (8.8) 
>3 300 (55.9) 33 (57.9) 
Central? 271 (50.5) 48 (84.1) 0.0006 
Peripheral$ 266 (49.5) 9 (15.9) 
Bobo-Dioula 90 (16.7) 15 (26.3) 
Mossi 106 (19.7) 11 (19.3) 
Peul 30(5.6) 2 (3.5) NS 
Senoufo 232 (43.2) 20 (35.1) 
Other 79 (14.8) 9 (15.8) 
*By  Pearson's chi-square test. NS = not significant. 
t Districts 1 to 3. 
*Districts 4 to 7. 
District 
Ethnic group 
and f&h months of pregnancy; therefore, only 
the measurements ofparasitemia performed dur- 
ing the five last months of pregnancy were con- 
sidered in the analysis. It was originally decided 
that every woman showing a parasitemia asso- 
ciated with cliical symptoms (body temperature 
> 37.5"C) would be treatedwith oral chloroquine 
(25 mg/kg for three days). None of the women 
demonstrated such an association during the fol- 
lowup. However, 57 women independently took 
a short treatment (usually at infratherapeutic 
doses) because they believed they had malaria. 
These women did not differ significantly from 
the remaining population, except for the area of 
residence (treatments were more frequent in the 
central districts [I-31 than in the peripheral dis- 
tricts [4-71) (Table 1). Therefore, they were in- 
cluded in the analysis. 
Influence of season and period of gestation 
There was no effect of the gestational period, 
but the LPD values were significantly higher dur- 
ing the rainy season than during the dry season 
(t = 3.39, degrees of freedom [dfl = 3,559, P < 
0.001). The LPD values were consequently ad- 
justed for the effect of the season by subtracting 
the mean LPD of the corresponding season from 
each individual LPD, and the MPD was com- 
puted for each woman. 
Risk factors influencing the MPD 
We first checked that MPD values were not 
different between the 57 self-treated women and 
the rest of the subjects (t = 0.26, df = 568, P > 
0.75). The results observed when testing the ef- 
fects of the five factors described above on the 
MPD are summarized in Table 2. No significant 
relationship between MPD and both the ethnic 
group and hemoglobin genotype was observed. 
The use of two-way analysis of variance showed 
that the effects of both the area of residence and 
the parity on MPD were significant (P < 0.003 
and P < 0.0001, respectively), and the interac- 
tion between these two factors was also signifi- 
cant (P < 0.008). The distribution of MPD val- 
ues by number ofgestations and area of residence 
is shown in Table 3, and there is a clear trend of 
decreasing MPD with increasing parity. The MPD 
values decreased significantly with age and the 
correlation coefficient computed between age and 
MPD was -0.32 (P < 0.0001). However, after 
adjustment of the MPD values for parity, there 
was no effect of age. 
The MPD values were then adjusted for the 
two remaining relevant factors,-area of residence 
and parity. Since a significant interaction be- 
tween these two factors was observed, the ad- 
justment was performed by subtracting the mean 
effect observed for the combination ofparity and 
area of residence to which she belonged from the 
MPD of each woman (28 possible combinations 
shown in Table 3). 
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Commingling analysis 
Assuming a unimodal distribution, the ad- 
justed MPD values were significantly skewed (x' 
= 202.6, df= 1, P < When we tested for 
a mixture of two skewed distributions against a 
single-skewed distribution, we found strong ev- 
idence for a bimodal distribution in the presence 
of residual skewness h2 = 73.7, df = 2, P < 
There was no evidence for a third com- 
ponent, regardless of whether skewness was ac- 
counted for or not. This result indicated that the 
high skewness observed in the adjusted MPD 
values comes from 1) a mixture of two distri- 
butions and 2) the fact that those two distribu- 
tions are skewed and need a power transforma- 
tion to restore normality. The distribution ofthe 
adjusted power-transformed MPD values and the 
predicted normal curves accounting for the pres- 
ence of two distributions are shown in Figure 1. 
The proportions of subjects in these two distri- 
butions are 95.4% and 4.6%, respectively, for 
those who present the lower and the upper MPD 
levels. 
DISCUSSION 
The heaviest infection intensities were ob- 
served among primigravidae and decreased pro- 
gressively with increasing number of gestations, 
confirming the major effect of parity on malaria 
infection during pregnancy reported in previous 
studies.!-' This finding can explain the high lev- 
els of placental malaria infection observed in pri- 
migravidae at delivery.8 Because age and parity 
are strongly correlated in tropical Africa, it was 
important to test whether the observed effect of 
age on the MPD was actual or confounding. The 
disappearance of this effect after adjustment for 
parity and the results of previous studies dem- 
onstrating an increased prevalence of parasit- 
emia in pregnant women compared with non- 
pregnant women ofthe same age1. 2.4. l 3  clearly 
show that parity is the relevant factor that influ- 
ences susceptibility to malaria in pregnant wom- 
en. The mechanisms underlying this increased 
susceptibility of primigravidae to malaria infec- 
tion remain unclear and may involve ncjnspecific 
immunosuppression due to pregnancy-associat- 
ed hormones such as cortisol,14 and impairment 
of the immune response to certain malaria 
antigen+ 15 An important practical implication 
of these results is that primigravidae are a high- 
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FIGURE 1. Distribution of the standardized power-transformed mean parasite densities (MPDs) after ad- 
justment for parity and area of residence, and predicted normal curves under the hypothesis of two distributions. 
risk group whose protection should be _a priority 
to reduce the morbidity and mortality of both 
women and children. 
The effect of the maternal residence is prob- 
ably due to geographic Merences in transmis- 
sion conditions (with some districts being locat- 
ed close to larval breeding areas). The significant 
interaction observed between this factor and par- 
ity is more difficult to explain. The data seem to 
indicate a potentialization of the deleterious ef- 
fect observed in primigravidae when they live in 
areas ofhigh transmission. The mechanisms that 
account for this observation warrant further in- 
vestigations. 
As expected, the peripheral parasite densities 
were significantly higher during the rainy season 
when transmission is the highest. Whereas cross- 
sectional studies have shown a decrease in par- 
asitemia prevalence with the period of gesta- 
t i ~ n , I - ~  we did not observe any effect ofthis factor 
on the levels of parasite density. However, our 
data were collected during the second half of 
pregnancy, whereas parasitemia has been found 
to be particularly frequent during the Jïrst and 
second trimester of ges t a t io~ l -~  
Whereas the. sickle cell and thalassemia traits 
are thought to afford a certain degree of protec- 
tion against malaria infection,16 we did not find 
any effect of hemoglobin genotype on the MPD. 
In particular, the mean MPD values observed 
among individuals heterozygous for the sickle- 
cell trait (hemoglobin AS) were quite similar to 
those observed in homozygous (AA) individuals 
(Table 4), a finding that is consistent with pre- 
vious studies that failed to demonstrate lower 
parasite rates in heterozygous (AS) individu- 
TABLE 4 
Distribution of standardized mean 1 SEM parasite density (MPD) values by hemoglobin genotype 
Genotype 
AC cc AA A§ 
387 n 
MPD -0.025 +. 0.05 0.004 i 0.14 -0.085 i 0.09 0.516 k 0.49 
38. 85 3 
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&.I7. Is  However, AS heterozygous children have 
been shown to be less frequently andless severely 
infected than homozygous AA normal individ- 
uals.L9-" These results support the view that the 
levels of immunity against P. falciparum ob- 
served in adults are such that the sickle-cell trait 
confers no advantage.z2 
Ten percent of the women in the study took 
antimalarial drugs during their pregnancy, usu- 
ally at infratherapeutic doses. They differed from 
the rest of the untreated women only in their 
area of residence, probably because access to 
medical care was easier in the central districts 
than in the peripheral ones. Their MPD values 
were similar to the MPD values of the other 
women of the study, and we do not think that 
this limited chemotherapy affected our results. 
On the other hand, some of these self-treated 
women might have selected themselves accord- 
ing to their susceptibility/resistance to malaria 
infection. In this case, their exclusion from the 
analysis could have introduced a bias that we 
wanted to avoid. 
Finally, the MPD values adjusted for panty 
and area of residence fitted a mixture of two 
distributions. This result is consistent with the 
presence of a major gene being involved in the 
determination ofthe malaria infection intensities 
among pregnant women; however, this should 
be confirmed by familial studies in this popu- 
lation. This possible genetic involvement is 
strongly supported by both our recent segrega- 
tion analysis performed on families from Cam- 
eroon, which showed evidence ofa recessive gene 
controlling blood infection levels in malaria,23 
and findings in mice that demonstrated the role 
of host genetic factors in the outcome of exper- 
imental malaria infe~tions.2~. Is Certain genetic 
disorders of red blood cells, such as sickle-cell 
anemia, thalassemia, ovalocytosis, and glucose- 
6-phosphate dehydrogenase deficiency are known 
to increase resistance against malaria infection 
in humans;16.z6 however, as mentioned above for 
abnormal hemoglobins, the importance of this 
protection remains unclear. Although genetic 
variants of the red blood cells have achieved 
polymorphic frequencies in many populations, 
the individual degree of protection afforded by 
them may only be quite sma1l.l6 
The role of HLA genes on the ability to re- 
spond to malaria infections has also been re- 
ported.27, 28 We intend to conduct familial studies 
in populations that are different from the one in 
our previous studyz3 to confirm the role of a 
major gene controlling susceptibility/resistance 
to malaria infection and to determine the rela- 
tionships of this gene with the genetic defects of 
red blood cells mentioned above and the HLA 
system. The identification of such a gene would 
have major implications in the control of ma- 
laria. 
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